(lp0
S"Intercept Pharmaceuticals Inc  Stock Could Be Biotech's Grand Slam Investorplace.com - Jan 24, 2017 The market has begun 2017 trading sideways, but don't let that fool you into thinking there aren't opportunities out there, especially in biotech."
p1
aS"Blog Coverage Intercept Pharmaceuticals Received NICE Approval for Ocaliva for ... Yahoo Finance - Mar 3, 2017 LONDON, UK / ACCESSWIRE / March 3, 2017 / Active Wall St. blog coverage looks at the headline from Intercept Pharmaceuticals, Inc.  as the Company announced on March 01, 2017, that UK's National Institute for Health and Care&nbsp;..."
p2
aS"This Analyst Bullish On Intercept Pharmaceuticals Inc  Long-Term Smarter Analyst - Feb 10, 2017 Intercept Pharmaceuticals Inc  shares rose as much as 9% during Friday's trading session, after the drug maker announced changes to its ongoing Ocaliva Phase 3 trial in NASH that increase probability of completing enrollment for interim&nbsp;...Intercept Pharma  to Provide Update on Phase 3 REGENERATE Trial of OCA ... - StreetInsider.comIntercept Pharmaceuticals Inc.  Moves Higher on Volume Spike for February 10 - Equities.com"
p3
aS'Charles Payne on Biotech: Biogen Inc , Intercept Pharmaceuticals Inc  Investorplace.com - Nov 29, 2016 Still, I am not interested in chasing drug names, as most of the large pharmaceutical companies have thin product pipelines and aging blockbusters.'
p4
aS"Intercept Pharma's liver drug wins conditional EU approval Reuters - Dec 14, 2016 Intercept Pharmaceuticals Inc said its liver drug received conditional approval from the European Commission to treat patients with primary biliary cholangitis , a rare liver condition.Stock Update : Intercept Pharmaceuticals Inc Receives Granted ... - Smarter Analyst"
p5
aS'The Intercept Pharmaceuticals Inc  Shares Sold by Credit Agricole SA Petro Global News 24 - Mar 14, 2017 Credit Agricole S A reduced its position in shares of Intercept Pharmaceuticals Inc  by 98.4% during the fourth quarter, Holdings Channel reports.Despite mixed analyst views, why Intercept Pharmaceuticals (NASDAQ: ICPT ... - FX Daily Report'
p6
aS"Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and ... GlobeNewswire  - Nov 3, 2016 NEW YORK, Nov. 03, 2016  -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today&nbsp;...Intercept Pharmaceuticals'  CEO Mark Pruzanski on Q3 2016 Results ... - Seeking AlphaIntercept  Reports Narrower-Than-Expected Q3 Loss November 03, 2016 - Zacks.com"
p7
aS'Why Is Intercept Stock Swinging So Wildly?  Investopedia - Jan 5, 2017 Intercept Pharmaceuticals Inc.  stock has been fluctuating wildly since late December, thanks in part to takeover speculation.'
p8
aS'Intercept Pharmaceuticals Reports Full Year 2016 Financial Results and ... GlobeNewswire  - Feb 23, 2017 NEW YORK, Feb. 23, 2017  -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today&nbsp;...Intercept Pharmaceuticals  Q4 2016 Results - Earnings Call Transcript - Seeking AlphaINTERCEPT PHARMACEUTICALS, INC.  Files An 8-K Results of ... - Market Exclusive'
p9
aS'Intercept Pharmaceuticals Appoints Sandip Kapadia as Chief Financial Officer GlobeNewswire  - Jun 9, 2016 NEW YORK, June 09, 2016  -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases, today&nbsp;...'
p10
a.